ConcertAI, a US-based company that deals with oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, announced on Monday that it has named Timothy (Tim) Albury as its new chief financial officer (CFO).
Albury, an accomplished finance executive, has served for 12 years at Arthur Andersen and around 25 years as CFO of various companies across multiple industry sectors. He has most recently served as CFO of AQuity Solutions. He was also a part of the leadership team growing KBI BioPharma, Osmotica Pharma, and Liquidia Corp (LQDA).
Albury said, 'ConcertAI is uniquely poised to expand its position as the clinical AI and Real-World Data leader. I am excited to join the talented ConcertAI team as the company enters a new phase of growth by bringing predictive and generative AI SaaS innovations to our customers in healthcare and clinical development.'
Indivior updates on Aelis Farma's Phase 2B study of AEF0117 for Cannabis Use Disorder
Vesper Bio announces positive Phase I results for FTD treatment
Empower Pharmacy names new president
Innovent's IBI363 receives US FDA Fast Track Designation
Valneva and Pfizer report positive Phase 2 booster results for Lyme disease vaccine
Grit Biotechnology's GT201 receives US FDA IND approval
Cereno Scientific doses first patient in Expanded Access Program for PAH
Medicilon USA begins operations at second R&D centre in Massachusetts
CS Genetics names new chief operating officer and chief scientific officer
Expanse Medical names new chief executive officer and FlowPhysix board member